MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • 2016 International Congress

    A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson’s disease

    C.C. Walton, L. Mowszowski, J.M. Shine, M. Gilat, J.M. Hall, C. O'Callaghan, A.J. Muller, M. Georiades, J.Y.Y. Szeto, K.A. Ehgoetz Martens, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

    Objective: To investigate the potential of cognitive training to improve symptoms of freezing of gait in Parkinson's disease. Background: Freezing of gait (FOG) is a…
  • 2016 International Congress

    Is the PPN a valuable target for deep brain stimulation in treatment of Parkinsonian disorders? Experience of a patient’s series

    I. Galazky, A. Kupsch, E. Wirkus, F. Casjens, S. Specht, H.J. Heinze, J. Voges (Magdeburg, Germany)

    Objective: Deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) has been reported to improve motor symptoms in idiopathic (IPS) and in atypical Parkinsonian syndromes…
  • 2016 International Congress

    Physical therapy, a third wheel in the management of Parkinson’s disease

    M.V. Alvarez, M. Rodriguez (San Antonio, TX, USA)

    Objective: To reinforce the importance of physical therapy in the management of Parkinson's disease. Background: Unsteadiness, falling, and tendency to fall are frequent symptoms of…
  • 2016 International Congress

    A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Feasibility and safety

    M.R. Landers, J.W. Navalta (Las Vegas, NV, USA)

    Objective: To test the feasibility and safety of a high-intensity exercise and fall prevention boot camp (HIBC) in people with Parkinson's disease (PD). Background: Most…
  • 2016 International Congress

    Functional motor outcomes after globus pallidus internus deep brain stimulation in Huntington´s disease – A case report

    T.T.C. Capato, R.G. Cury, R. Gimaães, E.T. Fonoff, M.S. Haddad (São Paulo, Brazil)

    Objective: The aim of this study was to analyse the motor outcome before and after 6 month follow-up in a HD patient treated by GPi-DBS.…
  • 2016 International Congress

    Has iCare PD started in Singapore?

    S.H.X. Liew, C. Cyq, N. Jcf, K. Sym, R.C.L. Ong (Singapore, Singapore)

    Objective: To evaluate if interdisciplinary care (iCare) is present in the management of Parkinson's disease (PD) among PD Allied Health Professionals (AHP) at a centre…
  • 2016 International Congress

    Feasibility, safety and effects of a group intervention based on European physiotherapy guideline for Parkinson´s disease

    J.E. Pompeu, T.B. Freitas, R.A. Nuvolini, K.G. Silva, F. Doná, R.A. Andreotti, N.A. Mazzini, M.G.R. Almeida, C. Torriani-Pasin (Sao Paulo, Brazil)

    Objective: To assess the feasibility, safety and effects of an group intervention based on European Physiotherapy Guideline. Background: Studies suggest that exercise may contribute to…
  • 2016 International Congress

    Understanding, predicting, and preventing falls in progressive supranuclear palsy

    B.R. Bluett, I. Litvan, S. Cheng, J. Juncos, Y. Bordelon, D.E. Riley, D. Standaert, S.G. Reich, D.A. Hall, B. Kluger, D. Shprecher, C. Marras, J. Jankovic (Las Vegas, NV, USA)

    Objective: To (1) evaluate which factors are associated with increasing falls in Progressive Supranuclear Palsy (PSP), unrelated to freezing; and (2) subsequently develop a predictive…
  • 2016 International Congress

    European physiotherapy guideline for Parkinson’s disease: Information for neurologists

    D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus (Nijmegen, Netherlands)

    Objective: We aim to inform physicians on the value of physiotherapy (PT) for people with Parkinson's disease (PwP) and on opportunities to optimize referral to…
  • 2016 International Congress

    Differential clinical outcomes in unifocal vs. multifocal premotor rTMS for Parkinson’s disease: A randomized trial

    M.C. Biagioni, A.Y. Son, S. Agarwal, G. Dacpano, M. Brys, P. Kumar, A. Cucca, J. Singleton-Garvin, R. Gilbert, A. Quartarone, A. DiRocco (New York, NY, USA)

    Objective: To compare changes in clinical outcomes after weekly low-frequency (LF) repetitive transcranial magnetic stimulation (rTMS) sessions over one vs. two pre-motor cortex (preMC) areas…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley